380 related articles for article (PubMed ID: 25240931)
41. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
42. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.
Staack RF; Fritschi G; Maurer HH
J Mass Spectrom; 2003 Sep; 38(9):971-81. PubMed ID: 14505325
[TBL] [Abstract][Full Text] [Related]
43. Determination of n-hexane metabolites by liquid chromatography/mass spectrometry. 2. Glucuronide-conjugated metabolites in untreated urine samples by electrospray ionization.
Manini P; Andreoli R; Mutti A; Bergamaschi E; Niessen WM
Rapid Commun Mass Spectrom; 1998; 12(21):1615-24. PubMed ID: 9807835
[TBL] [Abstract][Full Text] [Related]
44. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
Michely JA; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
[TBL] [Abstract][Full Text] [Related]
45. Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.
Meyer MR; Schmitt S; Maurer HH
J Mass Spectrom; 2013 Feb; 48(2):243-9. PubMed ID: 23378097
[TBL] [Abstract][Full Text] [Related]
46. Identification of rat urinary metabolites of rifabutin using LC-MSn and LC-HR-MS.
Prasad B; Singh S
Eur J Pharm Sci; 2010 Sep; 41(1):173-88. PubMed ID: 20558285
[TBL] [Abstract][Full Text] [Related]
47. Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn.
Meyer MR; Bach M; Welter J; Bovens M; Turcant A; Maurer HH
Anal Bioanal Chem; 2013 Jul; 405(19):6307-21. PubMed ID: 23774830
[TBL] [Abstract][Full Text] [Related]
48. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
[TBL] [Abstract][Full Text] [Related]
49. Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological and clinical activities.
Olatunji TL; Siebert F; Adetunji AE; Harvey BH; Gericke J; Hamman JH; Van der Kooy F
J Ethnopharmacol; 2021 Nov; 280():114476. PubMed ID: 34333104
[TBL] [Abstract][Full Text] [Related]
50. Mass Spectrometry Metabolomics and Feature-Based Molecular Networking Reveals Population-Specific Chemistry in Some Species of the
Reddy K; Stander MA; Stafford GI; Makunga NP
Front Nutr; 2022; 9():819753. PubMed ID: 35425789
[TBL] [Abstract][Full Text] [Related]
51. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.
Gopaul SV; Farrell K; Abbott FS
J Mass Spectrom; 2000 Jun; 35(6):698-704. PubMed ID: 10862121
[TBL] [Abstract][Full Text] [Related]
52. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
53. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
[TBL] [Abstract][Full Text] [Related]
54. Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants.
Wissenbach DK; Meyer MR; Remane D; Weber AA; Maurer HH
Anal Bioanal Chem; 2011 Apr; 400(1):79-88. PubMed ID: 21079926
[TBL] [Abstract][Full Text] [Related]
55. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
56. Analytical methodology for metabolomics study of adherent mammalian cells using NMR, GC-MS and LC-HRMS.
Madji Hounoum B; Blasco H; Nadal-Desbarats L; Diémé B; Montigny F; Andres CR; Emond P; Mavel S
Anal Bioanal Chem; 2015 Nov; 407(29):8861-72. PubMed ID: 26446897
[TBL] [Abstract][Full Text] [Related]
57. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
[TBL] [Abstract][Full Text] [Related]
58. Effects of Sceletium tortuosum in rats.
Loria MJ; Ali Z; Abe N; Sufka KJ; Khan IA
J Ethnopharmacol; 2014 Aug; 155(1):731-5. PubMed ID: 24930358
[TBL] [Abstract][Full Text] [Related]
59. Chiral analyses of dextromethorphan/levomethorphan and their metabolites in rat and human samples using LC-MS/MS.
Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
Anal Bioanal Chem; 2011 Apr; 400(1):165-74. PubMed ID: 21311876
[TBL] [Abstract][Full Text] [Related]
60. Automated software-guided identification of new buspirone metabolites using capillary LC coupled to ion trap and TOF mass spectrometry.
Fandiño AS; Nägele E; Perkins PD
J Mass Spectrom; 2006 Feb; 41(2):248-55. PubMed ID: 16421870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
